Overview of the Grant Writing Workshop From the GRAPPA 2020 Annual Meeting

As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. A. Ogdie, MD, MSCE, Associate Professor of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA. AO reports conflicts of interest with Amgen (Forward/National Databank), Novartis (University of Pennsylvania), Pfizer Inc. (University of Pennsylvania), AbbVie, Amgen, Bristol Myers Squibb, Celgene, Corrona, Eli Lilly, Janssen, Novartis, Pfizer Inc., Takeda Pharmaceutical Company, and UCB. CTR reports conflicts of interest with AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer Inc., and UCB. Address correspondence to Dr. A. Ogdie, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alogdie@pennmedicine.upenn.edu.

As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. A. Ogdie, MD, MSCE, Associate Professor of Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA. AO reports conflicts of interest with Amgen (Forward/National Databank), Novartis (University of Pennsylvania), Pfizer Inc. (University of Pennsylvania), AbbVie, Amgen, Bristol Myers Squibb, Celgene, Corrona, Eli Lilly, Janssen, Novartis, Pfizer Inc., Takeda Pharmaceutical Company, and UCB. CTR reports conflicts of interest with AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer Inc., and UCB. Address correspondence to Dr. A. Ogdie, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Email: alogdie@pennmedicine.upenn.edu.